PANAGORA ASSET MANAGEMENT INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 121 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$117,000
-75.2%
57,018
-64.5%
0.00%
-50.0%
Q2 2019$472,000
-88.1%
160,694
-84.8%
0.00%
-88.9%
Q1 2019$3,955,000
+37.8%
1,060,425
+47.8%
0.02%
+38.5%
Q4 2018$2,870,000
-20.2%
717,459
+10.9%
0.01%
-7.1%
Q3 2018$3,595,000
+177.8%
646,661
+95.8%
0.01%
+180.0%
Q2 2018$1,294,000
-65.8%
330,204
-58.9%
0.01%
-66.7%
Q1 2018$3,784,000
+36.9%
803,346
+20.0%
0.02%
+50.0%
Q4 2017$2,764,000
-37.9%
669,205
-4.7%
0.01%
-44.4%
Q3 2017$4,453,000
-24.8%
702,378
-7.0%
0.02%
-25.0%
Q2 2017$5,919,000
+13.3%
755,027
-4.3%
0.02%
+9.1%
Q1 2017$5,225,000
+88.8%
789,278
+97.9%
0.02%
+69.2%
Q4 2016$2,768,000
-25.6%
398,8880.0%0.01%
-27.8%
Q3 2016$3,718,000
+10.2%
398,888
+9.3%
0.02%
+5.9%
Q2 2016$3,374,000
+5.6%
365,112
-0.5%
0.02%
+6.2%
Q1 2016$3,195,000
+38.4%
366,829
+6.8%
0.02%
+45.5%
Q4 2015$2,309,000
+167.6%
343,550
+130.0%
0.01%
+120.0%
Q3 2015$863,000
-23.2%
149,366
+8.5%
0.01%
-16.7%
Q2 2015$1,123,000137,6350.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders